Mount Miriam Roche Cares Program

Press Release- Mount Miriam

PRESS RELEASE

For Immediate Release

ROCHE MALAYSIA RAISES FUNDS FOR CHILDREN WITH HEARING LOSS AT ITS ANNUAL ROCHE CHILDREN’S WALK

157 company sites unite for Roche Children’s Walk to raise funds for more than 75 projects around the world

children's walk

 

PETALING JAYA, June 25, 2018 – More than 400 Roche Malaysia employees organised  various activities to raise RM 40,000 for hearing impaired children to attend the Komuniti  TUTUR programme. From movie screening, bazaars and employee pledges, the joint  initiative by Roche Malaysia employees from the pharmaceutical and shared service centre,  culminated with a charity walk held in conjunction with Roche’s annual global event – the  Roche Children’s Walk.  

The Roche Children’s Walk is a traditional corporate social responsibility campaign of Roche  global, involving more than 100 sites around the world. Every June, more than 90,000 Roche  employees globally raise funds for philanthropic children’s projects within their countries. All  funds raised for local cause are then matched by Roche to contribute to a variety of non-governmental organisation (NGO) programmes in developing countries such as Malawi,  Ethiopia and the Philippines. For this year, through Roche’s global employee foundation,  three new education partnerships were initiated in Ethiopia, Nepal and Kenya. 

“In Malaysia we partnered with Yayasan Budi Penyayang, an NGO that supports the  Komuniti TUTUR Programme, an initiative by Universiti Kebangsaan Malaysia (UKM). The  TUTUR programme enables children, who receive cochlear implants to overcome their  hearing loss, to transition from clinic and integrate them into society through various  activities such as sound recognition and communication,” said Martin Kikstein, General  Manager of Roche Services (Asia Pacific) Sdn. Bhd., during the cheque presentation  ceremony at Sunway GEO recently. 

Komuniti TUTUR also has other components as part of its activities such as knowledge and  attitude building for parents, developing cochlear implant patients’ attitude, skill and  knowledge. 

“We are happy to support the children with hearing impairment to gain a better quality of life.  At Roche, patients are the centre of our operations. We firmly believe in the potential to  translate science into therapies, to address patient’s unmet needs and help them live longer  and healthier lives. The combined strengths of our pharmaceuticals and diagnostics services  – have made Roche the leader in personalised healthcare – a strategy that aims to fit the  right treatment to each patient in the best way possible,” said Lance Duan, General Manager, Roche (Malaysia) Sdn. Bhd., who was also present at the event. He also added that, “As  part of our annual corporate social responsibility initiative, we partner with organisations that  help improve the lives of disadvantaged children to provide them with a better quality of life.” 

Meanwhile, Dato’ Leela Mohd Ali, Chief Executive Officer of Yayasan Budi Penyayang  Malaysia, in her speech at the event, mentioned the support from Roche is important to  sustain the Penyayang-Komuniti TUTUR programme. “It has been a journey of 17 years of  working together with TUTUR to improve the lives of the hearing impaired children,” she said. Penyayang, she added, has signed a new Memorandum of Agreement with UKM to help continue the Penyayang-Komuniti TUTUR Programme.

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science  to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under  one roof have made Roche among the leaders in personalised healthcare – a strategy that  aims to fit the right treatment to each patient in the best way possible. 

Roche is one of the world’s largest biotech companies, with truly differentiated medicines in  oncology, immunology, infectious diseases, ophthalmology and diseases of the central  nervous system. Roche is also one of the world leaders in in vitro diagnostics and tissue based cancer diagnostics, and a frontrunner in diabetes management. 

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat  diseases and make a sustainable contribution to society. The company also aims to improve  patient access to medical innovations by working with all relevant stakeholders. Twenty-nine  medicines developed by Roche are included in the World Health Organization Model Lists of  Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.  Roche has been recognised as the Group Leader in sustainability within the  Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow  Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and  in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9  billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a  wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai  Pharmaceutical, Japan. For more information, please visit www.roche.com

Roche has been present in Malaysia since the 1950s, when the sales and distribution of  products was managed by a third party distributor. Since then, Roche has established its  operations to include Roche (Malaysia) Sdn. Bhd., the pharmaceutical business, Roche  Diagnostics (Malaysia) Sdn. Bhd. and Roche Services (Asia Pacific) Sdn. Bhd., the shared  service centre. With a total staff strength of over 550, Roche has grown into one of the  leading healthcare companies in Malaysia that provides holistic healthcare solutions  to healthcare practitioners and patients. For more information, please  visit www.roche.com.my.  

About Roche Children’s Walk: A day powered by employees

Roche Children’s Walk is the company’s global signature employee project. Since the first  company-wide walk in 2003, more than 220,000 Roche employees have participated, raising  more than CHF 17 million. All money collected by employees is matched by Roche and used  to support local children’s causes in communities where Roche operates, as well as in  developing countries such as Malawi, Ethiopia and the Philippines. Funds are applied to  local NGOs or channelled through the Roche Employee Action and Charity Trust (Re&Act), a  legally independent charity. For more information, please visit www.react.roche.com.  

All trademarks used or mentioned in this release are protected by law. 

For media enquiries, please contact: 

Zulfadli Yusmar ([email protected]) or Derek Fong  ([email protected]) at 03 – 79821750/51

 

RCW290618MYa